产前暴露于母亲COVID-19及围产期护理对新生儿结局的影响:INTERCOVID multinational cohort study结果
这项多国队列研究纳入18国43家机构,比较586例COVID-19孕妇与1535例无COVID-19孕妇的新生儿结局。母亲COVID-19与剖宫产率升高(52.8% vs 38.5%,P<.01)、早产及出生体重降低相关;剖宫产与新生儿阳性风险相关(OR 2.4,95%CI 1.2-4.7),而母乳喂养、肌肤接触和母婴同室未增加新生儿阳性风险。
要点
- 母亲COVID-19与剖宫产率升高(52.8% vs 38.5%,P<.01)及早产、出生体重降低相关。
- 宫内暴露>14天与新生儿检测阳性风险相关(OR 4.5,95%CI 2.2-9.4)。
- 剖宫产与新生儿COVID-19阳性风险相关(OR 2.4,95%CI 1.2-4.7)。
核心结论
- 在这项多国队列研究中,妊娠期COVID-19与母亲和新生儿并发症增加相关。
- 剖宫产与新生儿COVID-19诊断显著相关。
- 若产科和健康状况允许,阴道分娩应被视为最安全的分娩方式。
- 母亲与新生儿肌肤接触、母婴同室和直接母乳喂养不是新生儿COVID-19诊断的危险因素,确诊COVID-19的妇女可继续这些成熟的最佳实践。
研究设计与样本
- 这项队列研究于2020年3月至2021年3月在18个国家的43家机构进行。
- 每确定一名感染妇女后,立即按相同护理水平 concomitantly 纳入2名未匹配、连续、未暴露的妇女,可在妊娠或分娩任何阶段入组。
- 妇女和新生儿随访至出院。
- 妊娠期COVID-19由实验室确认和/或影像学肺部表现或≥2项预设COVID-19症状确定。
- 共纳入586名COVID-19诊断妇女所生新生儿和1535名无COVID-19诊断妇女所生新生儿。
主要发现
- COVID-19诊断妇女的剖宫产率高于无COVID-19诊断妇女(52.8% vs 38.5%,P<.01)。
- COVID-19诊断妇女的妊娠相关并发症(如妊娠期高血压疾病和胎儿窘迫)高于无COVID-19诊断妇女(均P<.001)。
- 母亲COVID-19诊断与早产率升高(P≤.001)及新生儿出生体重(P≤.001)、身长和头围降低相关。
- 在COVID-19诊断母亲中,宫内暴露时间>14天与新生儿检测阳性风险相关(OR 4.5,95%CI 2.2-9.4)。
- 在COVID-19诊断母亲所生新生儿中,剖宫产是COVID-19检测阳性的危险因素(OR 2.4,95%CI 1.2-4.7),即使考虑母亲病情严重程度并经多变量logistic分析后仍如此。
关键数值与推荐
- 在COVID-19诊断母亲所生新生儿亚组中,新生儿也阳性时结局恶化,新生儿重症监护室入住率、发热、胃肠道和呼吸道症状及死亡率更高,即使调整早产后仍如此。
- COVID-19诊断母亲的母乳喂养及医院新生儿护理实践(包括立即肌肤接触和母婴同室)与新生儿阳性风险增加无关。
临床怎么用
- 若产科和健康状况允许,阴道分娩应被视为最安全的分娩方式。
- 确诊COVID-19的妇女可继续肌肤接触、母婴同室和直接母乳喂养等成熟的最佳实践。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The effect of COVID-19 in pregnancy on maternal outcomes and its association with preeclampsia and gestational diabetes mellitus have been reported; however, a detailed understanding of the effects of maternal positivity, delivery mode, and perinatal practices on fetal and neonatal outcomes is urgently needed. OBJECTIVE: To evaluate the impact of COVID-19 on fetal and neonatal outcomes and the role of mode of delivery, breastfeeding, and early neonatal care practices on the risk of mother-to-child transmission. STUDY DESIGN: In this cohort study that took place from March 2020 to March 2021, involving 43 institutions in 18 countries, 2 unmatched, consecutive, unexposed women were concomitantly enrolled immediately after each infected woman was identified, at any stage of pregnancy or delivery, and at the same level of care to minimize bias. Women and neonates were followed up until hospital discharge. COVID-19 in pregnancy was determined by laboratory confirmation and/or radiological pulmonary findings or ≥2 predefined COVID-19 symptoms. The outcome measures were indices of neonatal and perinatal morbidity and mortality, neonatal positivity and its correlation with mode of delivery, breastfeeding, and hospital neonatal care practices. RESULTS: A total of 586 neonates born to women with COVID-19 diagnosis and 1535 neonates born to women without COVID-19 diagnosis were enrolled. Women with COVID-19 diagnosis had a higher rate of cesarean delivery (52.8% vs 38.5% for those without COVID-19 diagnosis, P<.01) and pregnancy-related complications, such as hypertensive disorders of pregnancy and fetal distress (all with P<.001), than women without COVID-19 diagnosis. Maternal diagnosis of COVID-19 carried an increased rate of preterm birth (P≤.001) and lower neonatal weight (P≤.001), length, and head circumference at birth. In mothers with COVID-19 diagnosis, the length of in utero exposure was significantly correlated to the risk of the neonate testing positive (odds ratio, 4.5; 95% confidence interval, 2.2-9.4 for length of in utero exposure >14 days). Among neonates born to mothers with COVID-19 diagnosis, birth via cesarean delivery was a risk factor for testing positive for COVID-19 (odds ratio, 2.4; 95% confidence interval, 1.2-4.7), even when severity of maternal conditions was considered and after multivariable logistic analysis. In the subgroup of neonates born to women with COVID-19 diagnosis, the outcomes worsened when the neonate also tested positive, with higher rates of neonatal intensive care unit admission, fever, gastrointestinal and respiratory symptoms, and death, even after adjusting for prematurity. Breastfeeding by mothers with COVID-19 diagnosis and hospital neonatal care practices, including immediate skin-to-skin contact and rooming-in, were not associated with an increased risk of newborn positivity. CONCLUSION: In this multinational cohort study, COVID-19 in pregnancy was associated with increased maternal and neonatal complications. Cesarean delivery was significantly associated with newborn COVID-19 diagnosis. Vaginal delivery should be considered the safest mode of delivery if obstetrical and health conditions allow it. Mother-to-child skin-to-skin contact, rooming-in, and direct breastfeeding were not risk factors for newborn COVID-19 diagnosis, thus well-established best practices can be continued among women with COVID-19 diagnosis.
引用
- Giuliani F, Oros D, Gunier RB, et al. Effects of prenatal exposure to maternal COVID-19 and perinatal care on neonatal outcome: results from the INTERCOVID Multinational Cohort Study. Am J Obstet Gynecol. 2022. PMID: 35452653. doi:10.1016/j.ajog.2022.04.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。